Tracheostomy in the coronavirus disease 2019 patient: evaluating feasibility, challenges and early outcomes of the 14-day guidance
- PMID: 32758308
- PMCID: PMC7445460
- DOI: 10.1017/S0022215120001759
Tracheostomy in the coronavirus disease 2019 patient: evaluating feasibility, challenges and early outcomes of the 14-day guidance
Abstract
Objectives: To report feasibility, early outcomes and challenges of implementing a 14-day threshold for undertaking surgical tracheostomy in the critically ill coronavirus disease 2019 patient.
Methods: Twenty-eight coronavirus disease 2019 patients underwent tracheostomy. Demographics, risk factors, ventilatory assistance, organ support and logistics were assessed.
Results: The mean time from intubation to tracheostomy formation was 17.0 days (standard deviation = 4.4, range 8-26 days). Mean time to decannulation was 15.8 days (standard deviation = 9.4) and mean time to intensive care unit stepdown to a ward was 19.2 days (standard deviation = 6.8). The time from intubation to tracheostomy was strongly positively correlated with: duration of mechanical ventilation (r(23) = 0.66; p < 0.001), time from intubation to decannulation (r(23) = 0.66; p < 0.001) and time from intubation to intensive care unit discharge (r(23) = 0.71; p < 0.001).
Conclusion: Performing a tracheostomy in coronavirus disease 2019 positive patients at 8-14 days following intubation is compatible with favourable outcomes. Multidisciplinary team input is crucial to patient selection.
Keywords: Coronavirus Disease 2019; Critical Care; Multidisciplinary Team; Personal Protective Equipment; SARS-CoV-2; Tracheostomy.
Conflict of interest statement
None declared
Figures





References
-
- World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. In: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technica... [14 May 2020]
MeSH terms
LinkOut - more resources
Full Text Sources